Azacitidine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
63323-771 -
Package NDC
63323-771-39 -
Application number
ANDA207518 -
SPL ID
4becda8d-8042-4cf1-bef3-c0ec3c23eebe -
SPL set ID
3b594aba-e798-4105-b801-0b0d970747c1 -
UNII
M801H13NRU -
RxCUI
485246
What the source publishes
- Labeler
- Fresenius Kabi USA, LLC
- Active ingredients
- Azacitidine
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Azacitidine",
"splId": "4becda8d-8042-4cf1-bef3-c0ec3c23eebe",
"labels": [
{
"setId": "3b594aba-e798-4105-b801-0b0d970747c1",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b594aba-e798-4105-b801-0b0d970747c1",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3b594aba-e798-4105-b801-0b0d970747c1"
}
],
"routes": [
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"labeler": "Fresenius Kabi USA, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-771-39) / 30 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "63323-771-39",
"identifierStatus": "well-formed",
"marketing_start_date": "20170316"
}
],
"productId": "63323-771_4becda8d-8042-4cf1-bef3-c0ec3c23eebe",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "63323-771",
"deaSchedule": null,
"genericName": "Azacitidine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AZACITIDINE",
"strength": "100 mg/30mL"
}
],
"applicationNumber": "ANDA207518",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20170316",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000233",
"N0000175595"
],
"upc": [
"0363323771393"
],
"unii": [
"M801H13NRU"
],
"rxcui": [
"485246"
],
"spl_set_id": [
"3b594aba-e798-4105-b801-0b0d970747c1"
],
"pharm_class_epc": [
"Nucleoside Metabolic Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleic Acid Synthesis Inhibitors [MoA]"
],
"manufacturer_name": [
"Fresenius Kabi USA, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:63323-771_4becda8d-8042-4cf1-bef3-c0ec3c23eebe"